Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
RSI has recently crossed above the critical value of 30 which means that the selling pressure has lessened and the internal strength of VPRS has increased. This is a positive for the stock and signals that, most likely, a bottom has formed.
The Stochastic Oscillator chart is registering a weak bullish signal as the %K has crossed above the %D. However, the oscillator is currently below the critical value of 20, identifying ALCL as oversold. Watch for the oscillator to move above 20 which will increase the bullishness of this signal.
I doubt this stock will move though. Company looks too shifty
GL though
yup! looks like another pump and dump scam established
too many flippers/Day traders. Won't run without substantial news.
someone got some nice 2's
looks like this RM is falling apart
Market doesn't lie. These guys sank this stock. Scam proven
Time to report these criminals
The MACD is presently bullish because it is above the signal line (a 9 day exponential moving average). However, it is beneath the critical level of 0, which means that the underlying moving averages are still bearish, but converging towards bullish!!
Good luck. its coming folks.
Hoping for a great week!!!
Considering where the stock is sitting today and the insiders purchase I'd suggest they hire a better promo company should that be the case.
another otc scam. Garbage company
If you cannot consummate a deal of a “mountain” holding vast enormous amounts of precious metals! with today’s market prices…. Then agreed …..scam! Also no back up proof of any deal other than hocus pocus carrot dangling words. Thus allowed on OTC markets.
Take a loss before loss season starts move on.
PS, I’ve done my DD and owned and sold this with both gain and loss. So go ahead and type a wishfull retort..
Garbage Company
GL
This is all good, nothing has changed with Atlas. Other than the price drop somewhat today (prob due to panic of reporting change). They will save alot of $$$ on reporting fees. You can also excpect to see a lot more companies following suit.
"It may take awhile for investors and issuers to come to the conclusion there is no real difference between an OTCBB® listed security and a Fully Reporting Issuer trading on the Pink Sheets now under the OTCQB designation."
UPDATE (2/28/11): From OTCBB.com – FINRATM is updating the comment on the OTCBB Daily List used to indicate an issue is no longer eligible for quotation on the OTCBB due to a lack of quotation activity. The new comment will be “Ineligible for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11”. This replaces the previous comment “Failure to comply with Rule 15c2-11
GL
another good way to start the reporting on these guys.
https://denebleo.sec.gov/TCRExternal/index.xhtml
Due to the magnitude of the revenues they are claiming with MediPharm Pharmaceuticals this could take a little more time. When it does come to fruition...this could be as stockguru predicts... $$$
Still holding
GL
very strong management with excellent back ground!!!!!!
hopefully news before this Sept. Good Luck!!
Refreasher
Form 8-K for VIPER RESOURCES,INC.
--------------------------------------------------------------------------------
5-May-2011
Change in Directors or Principal Officers
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS, APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENT OF CERTAIN
OFFICERS
Effective April 25, 2011 Dianwen Ju was appointed to serve as a member of our
board of directors. Immediately following Mr. Ju's appointment, Massimiliano
Pozzoni resigned as a director and as our sole executive officer. Upon Mr.Pozzoni's resignation as our sole executive officer, the following persons were appointed to serve in the following offices:
President and Chief Executive Officer: Dianwen Ju
Treasurer: Jimmy Wang
Chief Financial Officer Xiao Chen
Secretary Vincent Wang
Dianwen Ju, Ph.D., 43, received a Ph.D. degree in Immunology in 1999, a Master's degree in Pharmacology in 1994, and a Bachelor's degree in Pharmacy in 1991 in Second Military Medical University, Shanghai, China. He joined Shanghai MediPharm Biotech in 2002 as a director of R&D and he is currently CEO and Chairman of MediPharm Biotech Pharmaceuticals Co. Ltd (Bermuda). He is also a Research Professor in Fudan University, Shanghai, China. He has 20 years of R&D experiences in biological drugs and new therapies for the treatment of malignant cancer. He has more than 40 publications in peer-reviewed international journals including Journal of Clinical Oncology, Cancer Research, Gene Therapy, International Journal of Oncology, Cancer Gene Therapy, Cancer Immunology & Immunotherapy, et al. He has invented 15 biotechnologies of which 8 are patented and the remainings are pending. Before joining MediPharm in 2002, Dr. Ju had been an assistant director and a senior scientist in Shanghai Brilliance Biotech Institute and a lecturer in Immunology in Second Military Medical University for 6 years.
Jimmy Wang, 45, is the Chief Financial Officer of American Compass, Inc., where he has served, initially as Chief Accounting Officer, since 2003. Prior to joining American Compass, Inc., he served as an accounting manager for Planned Parenthood of the Greater Miami Valley from 2000 to 2003. He has served as a Director for Nevada Gold Holdings, Inc. since January 25, 2011. He is a graduate of the City University of New York, where he majored in both Accounting & Information Systems and Economics.
Xiao Chen, 39, worked at Brilliance China Group from 1994 to 2001. From 2005 to 2008, he worked as director of finance at Shanghai Medipharm Co. Ltd. Since 2008, Mr Chen has been working at Hybrid Kinetic Group Limited as vice general manager of investments in China. Mr Chen holds a bachelor's degree in investment management from Shanghai Finance University.
Vincent Wang, 37, has been the Secretary and a Director of Nevada Gold Holdings, Inc. since November 24, 2010. Mr. Wang has been Vice President of Hybrid Kinetic Motors Corp. since 2009 and has also served as a director of American Compass, Inc, a wholly-owned subsidiary of Hybrid Kinetic Group Limited, since 2009. Mr Wang has extensive experience in educational and linguistic fields. He holds a masters degree in linguistics from National Taiwan Normal University.
--------------------------------------------------------------------------------
ITEM 8. OTHER INFORMATION
Effective April 25, 2011 Massimiliano Pozzoni sold 35,000,000 shares of common stock standing in his name to Chimerica Capital, LLC. Jimmy Wang has the power to vote and dispose of the shares transferred to Chimerica Capital, LLC.
Form 8-K for VIPER RESOURCES,INC.
--------------------------------------------------------------------------------
5-May-2011
Change in Directors or Principal Officers
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS, APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENT OF CERTAIN
OFFICERS
Effective April 25, 2011 Dianwen Ju was appointed to serve as a member of our
board of directors. Immediately following Mr. Ju's appointment, Massimiliano
Pozzoni resigned as a director and as our sole executive officer. Upon Mr.
Pozzoni's resignation as our sole executive officer, the following persons were
appointed to serve in the following offices:
President and Chief Executive Officer: Dianwen Ju
Treasurer: Jimmy Wang
Chief Financial Officer Xiao Chen
Secretary Vincent Wang
Dianwen Ju, Ph.D., 43, received a Ph.D. degree in Immunology in 1999, a Master's degree in Pharmacology in 1994, and a Bachelor's degree in Pharmacy in 1991 in Second Military Medical University, Shanghai, China. He joined Shanghai MediPharm Biotech in 2002 as a director of R&D and he is currently CEO and Chairman of MediPharm Biotech Pharmaceuticals Co. Ltd (Bermuda). He is also a Research Professor in Fudan University, Shanghai, China. He has 20 years of R&D experiences in biological drugs and new therapies for the treatment of malignant cancer. He has more than 40 publications in peer-reviewed international journals including Journal of Clinical Oncology, Cancer Research, Gene Therapy, International Journal of Oncology, Cancer Gene Therapy, Cancer Immunology & Immunotherapy, et al. He has invented 15 biotechnologies of which 8 are patented and the remainings are pending. Before joining MediPharm in 2002, Dr. Ju had been an assistant director and a senior scientist in Shanghai Brilliance Biotech Institute and a lecturer in Immunology in Second Military Medical University for 6 years.
Jimmy Wang, 45, is the Chief Financial Officer of American Compass, Inc., where he has served, initially as Chief Accounting Officer, since 2003. Prior to joining American Compass, Inc., he served as an accounting manager for Planned Parenthood of the Greater Miami Valley from 2000 to 2003. He has served as a Director for Nevada Gold Holdings, Inc. since January 25, 2011. He is a graduate of the City University of New York, where he majored in both Accounting & Information Systems and Economics.
Xiao Chen, 39, worked at Brilliance China Group from 1994 to 2001. From 2005 to 2008, he worked as director of finance at Shanghai Medipharm Co. Ltd. Since 2008, Mr Chen has been working at Hybrid Kinetic Group Limited as vice general manager of investments in China. Mr Chen holds a bachelor's degree in investment management from Shanghai Finance University.
Vincent Wang, 37, has been the Secretary and a Director of Nevada Gold Holdings, Inc. since November 24, 2010. Mr. Wang has been Vice President of Hybrid Kinetic Motors Corp. since 2009 and has also served as a director of American Compass, Inc, a wholly-owned subsidiary of Hybrid Kinetic Group Limited, since 2009. Mr Wang has extensive experience in educational and linguistic fields. He holds a masters degree in linguistics from National Taiwan Normal University.
--------------------------------------------------------------------------------
ITEM 8. OTHER INFORMATION
Effective April 25, 2011 Massimiliano Pozzoni sold 35,000,000 shares of common stock standing in his name to Chimerica Capital, LLC. Jimmy Wang has the power to vote and dispose of the shares transferred to Chimerica Capital, LLC.
you'd think they would at least take some pointers from LE*G or such and do some major promoting if this is indeed a scam...atleast they could make some real $$$ first to pay for some good lawyers....lol
in any event, we'll definetly know come 3 weeks
then move on!
while your're at it, do some reading
http://www.investopedia.com/articles/stocks/09/introduction-reverse-mergers.asp#axzz1UAUrkAlE
pretty gusty scam filing under an Executive Branch of Colorado's state government
nice try!
May 6th 2011, VPRS issued an 8k, a change of CEO and ownership. Essentially, judging from the 8k, the shell was purchased for 35 million shares of stock, at what price we do not know.
your posted filings are back in Feb, VPRS is in a whole new ball game now.
OPT
Little bid whacking on the asks will not make this stock run, and people on this board will not make it run either. Price movements between 7 and 4 cents are miniscule. If an RM takes place with a giant such as Crocus Grp, it will have to hit the wires and then the MM’s, institutional buying powers with major cash will take notice and thus a major price run should occur.
Good Luck
Dave thanks for this intel.
Question, if an agreement was made in Russia in an open and public the setting why wouldn't they just announce it here?
I made up a hypothetical chart on % /price movements on what we would potentially see with some serious volume. This is based on Fridays price movement of 18.75% or .003 cts per share, so I used that scenario for example.
PERCENTAGE INCREASE CHART
EXAMPLES
Price 0.016
Volume Increase % Price increase Price Stock
10,000 18.75% 0.001875 0.003 0.019
20,000 38% 0.00375 0.006 0.022
40,000 75% 0.0075 0.012 0.028
80,000 150% 0.015 0.024 0.040
160,000 300% 0.03 0.048 0.064
320,000 600% 0.06 0.096 0.112
640,000 1200% 0.12 0.192 0.208
1,280,000 2400% 0.24 0.384 0.400
2,560,000 4800% 0.48 0.768 0.784
5,120,000 9600% 0.96 1.536 1.552
10,240,000 19200% 1.92 3.072 3.088
20,480,000 38400% 3.84 6.144 6.160
Keep in mind, stocks like GWAY and LEXG, etc, have had trading volumes ranging over 12 mill in a span of days. If this RM happens, would could easy see over 10 per share extremely fast.
Of course weirder things have happened in the universe.
cheers
wrong board sorry
B.C. man hit with $7.2 million fine in SEC case
Vancouver resident Brent Pierce has been hit with an administrative penalty after a U.S. judge found that he sold unregistered shares of Lexington Resources
link
http://www.stockhouse.com/Community-News/2011/Jul/29/B-C--man-hit-with-$7-2-million-fine-in-SEC-case
on a further note; RBC shows
Company Details
Sector
Capital Goods
Industry
Constr. & Agric. Machinery
Exchanges
OTC
Employees 800
Founded
N/A
I find it strange RBC thinks or better yet knows 800 people are working for Allied Products but the OTC cannot contact or find the location of anyone.
Hopefully we hear something soon. GL
with this potential RM and expected revenues from Medipharm biotech, it should take this well beyond LEXG 52 week high(I'm hoping).
I hope you're right on the RM, I've been here awhile finally signed up (more so due to lazyness) nevertheless, I'm invested here but makes a person nervous when you see.
"Investors are advised that OTC Markets Group has been unable to contact or confirm the location of this company. If you have current contact information, please complete the Update Company Information Form or send an email to info@otcmarkets.com".
http://www.otcmarkets.com/stock/ADPC/company-info
crossing my fingers